Dorsomorphin or Compound C, the only known AMPK-specific inhibitor augmented the anti-cancer effects of Aspirin against HER-2-positive breast cancer in an AMPK-independent manner, by regulating lipid metabolism mediated by c-myc (127). Here, PRKAA1 is linked to cancer.